Boostrix-IPV

diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Boostrix-IPV, covering 2016-09-15 to 2016-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV) [Phase 4]